T
here have been few reports on the prevalence of congenital upper extremity anomalies. These epidemiology data are important to allow the identification of risks to the public health. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The most striking example is that of thalidomide, 1 the medication used in the late 1950s and early 1960s for pregnancy-related nausea, which caused severe birth anomalies of the extremities. Another example, especially pertinent for New York State, is Love Canal, a neighborhood in Niagara, New York. Love Canal gained attention in the 1970s when previously buried toxic waste leaked and created a public health "emergency" and, eventually, was associated with birth anomalies. Ultimately, these public health catastrophes prompted the development of many of today's state and national registries. Appropriate funding and monitoring of registries have the potential to avoid or minimize the adverse affects from such risks to the public health. In addition, an understanding of prevalence allows appropriate resource utilization including training and research expenditures.
Three studies inform our understanding of upper extremity birth anomalies. Giele et al 2 utilized a total population study of Western Australia over 11 years and reported an upper limb anomaly prevalence of 1 in 506 live births (19.8 per 10,000 live births). Koskimies et al 3 evaluated the Finnish Registry of Congenital Malformations over 13 years and found an incidence of upper limb abnormalities of 5.25 per 10,000 live births. And Ekblom et al, 4 utilizing multiple registries in Sweden, documented a national upper limb anomaly incidence of 21.5 in 10,000 live births. The variability is based on differing populations, registry differences, and different inclusion criteria. Nonetheless, these data help frame any discussion of the impact of congenital upper limb anomalies on society.
The prevalence figures noted above share a commonality of being products of well-developed national or regional registry systems and patient populations with decreased mobility. Prevalence data in the United States have been challenging as the registries are less well developed and more focused on severe, systemic conditions rather than upper extremity anomalies. The limited data that are available are state-based only. Additional challenges for a registry in the United States include a much larger and more mobile population. Commonly referenced prevalence figures for the United States are most often clinic visit data or local population data 5-7 these have provided estimates of prevalence at 11.4 to 16 per 10,000 births.
The purpose of this investigation was to utilize the New York Congenital Malformation Registry (NYCMR) to assess the prevalence of congenital upper extremity limb anomalies in the defined populations of New York City and New York State.
METHODS
Institutional Review Board approval was obtained for this investigation. We reviewed the NYCMR from 1992 to 2010 to identify cases of upper extremity congenital anomalies; all data were blinded. The NYCMR was begun in 1982 funded in response to the thalidomide and the Love Canal pollution disasters. 8 It is one of the largest such registries in the country and annually includes approximately 11,000 children with birth anomalies among 270,000 live births. 9 The registry identifies patients with congenital anomalies among live births in the state of New York. Hospitals and health care providers are required to report specific malformations identified in children up to 2 years of age. There are defined requirements for physician and hospital reporting and the NYCMR staff fills information deficits with the patient medical record; additional information may be requested and the Medical Director may become involved if there is uncertainty with diagnosis.
Each report is compared against previous entries to prevent duplication. Periodic audits and regular assessments of accuracy and comprehensiveness are performed including a review of discharge data, discharge summaries, and on-site audits. 9 The data ascertainment for this registry is considered, therefore, a combination of active and passive. The sensitivity of the NYCRM data has been estimated at 86.5%, 11 . Significance was set at P < 0.05 and 95% confidence intervals were computed. confidence intervals, 0.267%-0.277%) were affected, a prevalence rate of 27.2 per 10,000 live births (Table 1) . Table 1 summarizes our findings. Polydactyly was the most common diagnosis but the data did not allow a reliable separation of preaxial and postaxial polydactyly. Reduction defects considered together were next most common, including transverse deficiency, longitudinal deficiency, and split hand anomaly. Syndactyly of the hand and foot were less frequently noted.
There were 215 children identified with a syndrome or association, a prevalence of 0.44 per 10,000 live births. The most common of these was Amniotic Constriction Band with 78 cases. Table 1 provides further details on the cohort as a whole including confidence intervals and prevalence breakdowns.
The data were divided into City and State cohorts allowing data comparison for the 19 years in total. Table 2 provides a breakdown with a comparison of anomaly prevalence between the 2 groups. There were significantly more patients with polydactyly in the New York City group, with a prevalence of 29.9 compared with 17.5 per 10,000 live births in the New York State group, P < 0.0001. However, for all other diagnoses and syndromes, there were significantly more anomalies in the New York State group.
DISCUSSION
In the United States, data from the National Birth Defects Prevention Network (NBDPN) have been utilized to assess major birth anomalies and are tracked annually. To date, there have been few assessments of specific limb anomalies with the available surveillance data; our understanding of extremity congenital anomalies has the potential to be greatly increased with further study. Two recent works highlight the benefits of assessing registry data. Chen et al 12 assessed the risk of maternal caffeine consumption and congenital limb deficiencies. A weak increased risk of limb deficiency related to caffeine consumption was identified but this did not vary based on the amount of caffeine consumed. Parker et al 13 reported the prevalence of clubfoot using several surveillance programs and confirmed associations with maternal age, parity, education, and marital status.
The utility of the NBDPN has been demonstrated with a number of assessments of major birth anomalies. There are 30 population-based surveillance programs that compromise the NBDPN and report data on 45 major birth anomalies. Parker et al 14 reported the prevalence of selected upper extremity birth defects from 2004 to 2006 using 14 of these programs to assess 21 birth anomalies and to report estimated national prevalence data. The prevalence of upper extremity reduction defects was estimated to be 3.49 per 10,000 live births with an estimated 1454 annual cases. In a more recent study focusing on race/ethnicity utilizing 12 of the surveillance programs (approximately 1 in 3 US births), the prevalence of upper extremity reduction defects was found to be 2.85 per 10,000 live births. 15 These population-based studies provide a useful but basic view of congenital anomalies with only broad information on the prevalence of reduction defects. There are no granular data on different types of reduction defects, such a radial longitudinal deficiency or cleft hand, or information on other upper extremity anomalies such as polydactyly or syndactyly. A comparison of 3 of the large "State" registries in the United States demonstrates grossly similar findings despite differences in the registry programs. 8 Using prevalence data from 1995 and 1996, upper extremity reduction defects varied from 2.7 (NYCMR) to 3.9 (MACDP) to 4.1 (California Birth Defects Monitoring Program) per 10,000 births. The NYCMR includes only live births and is a mixed active and passive case ascertainment program, 2 factors likely accounting for at least some of the difference compared with the other 2 registries.
In the most specific prior report, Correa et al 16 assessed the MACDP data between the years of 1968 and 2003 to assess a variety of congenital anomalies. This population-based surveillance of 5 counties around Atlanta, GA is highly regarded given its durability and data acquisition methods. There is multisource active case ascertainment in children up to 6 years of age with data and clinical review of all cases.
In this report, there were 32,938 total anomalies among the 1,232,191 births for an anomaly prevalence of 26.7 per 10,000 live births. An assessment of upper extremity anomalies identified 1913 children with polydactyly (a prevalence of 15.53 per 10,000 live births), 377 with a transverse limb deficiency (3.06/10,000), 176 with a longitudinal limb deficiency (1.43/10,000), 49 with a split hand and/or split foot anomaly (0.40/10,000), and 40 with an intercalary limb deficiency (0.32/10,000). These data vary somewhat from our findings as summarized in Table 1 .
A comparison of New York City and New York State anomaly prevalence over the 19-year study period demonstrated that polydactyly was more frequent in New York City, whereas all other anomalies were more common in New York State. This difference in polydactyly prevalence is likely explained by the racial disparity between the population of New York City and New York State. In 2013, 25.5% of the population of the New York City was African American, whereas New York State (exclusive of New York City) was only 8.7% African American. 17 Given that postaxial polydactyly is found predominately in African Americans, the higher prevalence of polydactyly in New York City is not surprising. The MADCP data also confirmed notable differences along racial lines for polydactyly. The prevalence of polydactyly was 11.61 per 10,000 for whites, 23.18 per 10,000 in African Americans, and 12.16 per 10,000 in Hispanics. Furthermore, the higher percentage of African Americans in both the NYCMR and the MACDP populations likely account for prevalence differences compared with the Scandinavian (5.9 per 10,000) 4 and Australian data ( Table 3) . The NYCMR population differed from previous reports for 2 other conditions. Longitudinal deficiency was present in 0.5 per 10,000, notably less than the Swedish and Finnish populations at 3.1 4 and 2.1 3 per 10,000, respectively. In addition, there were 172 cases of radial longitudinal deficiency and 36 cases of ulnar longitudinal deficiency, a ratio of approximately 5:1. Although traditional reports have cited an even higher difference in prevalence, Ekblom et al's 4 recent Swedish epidemiological study demonstrated a prevalence of 1.3 and 1.0 for radial longitudinal deficiency and ulnar longitudinal deficiency per 10,000 births, respectively. In addition, there is a seemingly low prevalence of syndactyly at 1.3 per 10,000. This is lower than expected and likely excludes partial syndactyly and may relate to underreporting of complete syndactyly; however, the prevalence is remarkably similar to the Swedish prevalence of 1.4. 4 This does call into question a long held belief that syndactyly is the most common, or second most common, congenital anomaly. [18] [19] [20] Our report is limited by the weaknesses of any registry report. The NYCMR utilizes a mixed case ascertainment with passive inclusion and active confirmation. It is an imperfect registry for the identification of specific upper extremity congenital anomalies as confirmation of such anomalies often requires clinical and radiographic data assessment by upper extremity experts (ie, a congenital hand surgeon). Within the data analyzed, we believe that the polydactyly and syndactyly data are the most reliable as these cases were easiest to identify and did not require inclusion "rules." In contrast, the cases of reduction defects are least reliable due to variability in coding and the fact that these diagnoses are less straightforward to diagnose.
In conclusion, using the NYCMR database of nearly 5 million live births, we found the prevalence of upper extremity congenital anomalies to be 27.2 per 10,000 births. Polydactyly was the most common anomaly with a prevalence of 23.4 per 10,000 births, and syndactyly and reduction defects were somewhat less common. Although registry data are imperfect, we believe these data from New York provide useful information on upper extremity birth anomalies. 
